Simplex Trading
OLMA icon

Simplex Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Simplex Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$532K Buy
35,700
+6,400
+22% +$142K ﹤0.01% 3181
2025
Q4 		$733K Sell
29,300
-42,900
-59% -$763K ﹤0.01% 2928
2025
Q3 		$706K Buy
72,200
+24,600
+52% +$148K ﹤0.01% 3416
2025
Q2 		$202K Buy
47,600
+46,600
+4,660% +$208K ﹤0.01% 4494
2025
Q1 		$3K Sell
1,000
-47,000
-98% -$236K ﹤0.01% 7851
2024
Q4 		$279K Buy
48,000
+40,700
+558% +$407K ﹤0.01% 4147
2024
Q3 		$87K Sell
7,300
-5,000
-41% -$63.9K ﹤0.01% 5375
2024
Q2 		$133K Buy
12,300
+9,400
+324% +$102K ﹤0.01% 5065
2024
Q1 		$32K Sell
2,900
-8,100
-74% -$105K ﹤0.01% 6703
2023
Q4 		$154K Buy
11,000
+5,500
+100% +$73.9K ﹤0.01% 4945
2023
Q3 		$67K Buy
5,500
+5,100
+1,275% +$52K ﹤0.01% 5526
2023
Q2 		$3K Buy
+400
New +$2.42K ﹤0.01% 8255
2022
Q1 		– Sell
-1,700
Closed -$15K – 11115
2021
Q4 		$15K Buy
+1,700
New +$35.2K ﹤0.01% 8693

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Simplex Trading's OLMA Position: Q1 2026 in Review

Simplex Trading increased its Olema Pharmaceuticals (OLMA) stake by 109% in Q1 2026, buying an estimated $129K and bringing the position to 11,127 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #4524.

Simplex Trading first reported a position in OLMA in Q4 2021 and has held it in 12 quarters since. The position peaked at $261K in Q4 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Simplex Trading held 11,127 shares of Olema Pharmaceuticals worth $166K as of Q1 2026.
  • Simplex Trading bought 5,806 Olema Pharmaceuticals shares in Q1 2026, an estimated $129K.
  • Olema Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4524 holding.
  • Simplex Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
  • Simplex Trading's Olema Pharmaceuticals position peaked at $261K in Q4 2023.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.